Health Care

2024 posts

" Revive Therapeutics (CSE:RVV) & PharmaTher (CSE:PHRM) sign MDMA research collaboration agreement

Revive Therapeutics (RVV), and PharmaTher (PHRM) have signed a research collaboration agreement.
  • Jon Brown
  • 2 mins
  • 03 February 2023 12:15 (EST)
  • 124

" Defence Therapeutics (CSE:DTC) and CQDM to fund new cancer vaccine platform

Defence Therapeutics (DTC) and CQDM to fund the development of a new cancer vaccine platform.

" CENTR (CSE:CNTR) enters esports with an OpTic Gaming Media partnership

CENTR Brands (CNTR) has a new gaming influencer partnership with OpTic Gaming, a global esports and entertainment organization.

" Fobi (TSXV:FOBI) signs new PulseIR deal with Empower Clinics

Fobi AI (FOBI) announced that its wholly-owned subsidiary, PulseIR, has signed a new deal with Empower Clinics.

" Numinus (TSX:NUMI) receives Health Canada approval for psychedelic tea therapy

Numinus Wellness (NUMI) has received approval from Health Canada for its experiential training study.
Small Pharma team

" Small Pharma (TSXV:DMT) adds two new patents to its portfolio approved for issue

Small Pharma (DMT) has had two patents approved by the U.S. Patent & Trademark Office to further build up its portfolio.
  • Jon Brown
  • 2 mins
  • 01 February 2023 13:00 (EST)
  • 90
Namaste Technologies Inc. - CEO, Meni Morim.

" Lifeist Wellness (TSXV:LFST) closes second tranche with alumina partners

Health-tech company, Lifeist Wellness Inc. (LFST), has completed a second tranche payment of $260,335 for its draw-down equity facility with Alumina Partners Ltd.

" DiagnaMed Holdings (CSE:DMED) incorporates OpenAI’s ChatGPT into its Brain Health Digital Platform

DiagnaMed Holdings (DMED) will incorporate OpenAI’s technology, ChatGPT, in its BRAIN AGE Artificial Intelligence Product Suite.
Cybin - CEO, Doug Drysdale (first from left).

" Cybin (NEO:CYBN) announces first-in-human dosing of its DMT molecule

Cybin (CYBN) will initiate the first-in-human dosing of its proprietary deuterated DMT molecule, CYB004.

" Irwin Naturals (CSE:IWIN) signs LOI to acquire Braxia Scientific (CSE:BRAX)

Irwin Naturals Inc. (IWIN) has signed an amended LOI to acquire medical and psychedelic research company Braxia Scientific Corp. (BRAX).
The Market Herald Video

" Numinus Wellness: The mental health business is estimated to grow to $530 billion by 2030

Welcome to the Market Herald, I’m Brieanna McCutcheon, and this is The Top Line.
Sona Nanotech (CSE:SONA) - CEO, David Regan

" Sona Nanotech (CSE:SONA) to acquire cancer therapy developer Siva Therapeutics

Sona Nanotech (SONA) has signed an agreement to acquire Siva Therapeutics Inc.

" Irwin Naturals (CSE:IWIN) signs LOI to acquire Braxia Scientific (CSE:BRAX)

Irwin Naturals (IWIN) has signed a letter of intent for a business combination with Braxia Scientific Corp. (BRAX).
Reliq Health Technologies - CEO Dr. Lisa Crossley

" Reliq Health Technologies (TSXV:RHT) announces 30 new skilled nursing facility clients and a new contract in Texas

Reliq Health Technologies (RHT) has added 30 new skilled nursing facility clients in Florida and a large allergy and respirology clinic in Texas.

" Acerus (TSX:ASP) files for CCAA protection

Acerus Pharmaceuticals Corporation (ASP) and its subsidiaries have received an order for creditor protection.
The Market Herald Video

" PharmAla Biotech (CSE:MDMA) granted an export permit for 300 grams of LaNeo MDMA

PharmAla Biotech (MDMA) and its manufacturing partners have received an export permit for 300 grams of its LaNeo MDMA.

" Lobe Sciences (CSE:LOBE) signs agreement with Integrative Headache Medicine of New York

Lobe Sciences Limited (LOBE) has signed an Investigator Initiated Research Agreement with Lauren R. Natbony, MD, FAHS.

" Renaissance BioScience Corp. and Timeless Capital Corp. (TSXV:TLC.P) sign LOI

Timeless Capital Corp. (TLC.P) has signed a non-binding letter of intent with Renaissance BioScience Corp.